Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HELEN HESLOP and LEONID METELITSA.
HELEN HESLOP
Connection Strength
0.378
LEONID METELITSA
  1. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
    View in: PubMed
    Score: 0.186
  2. Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy. N Engl J Med. 2026 Sep 10; 395(10):1029-1032.
    View in: PubMed
    Score: 0.062
  3. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025 01; 637(8047):940-946.
    View in: PubMed
    Score: 0.055
  4. Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq. 2024 Apr 03.
    View in: PubMed
    Score: 0.053
  5. Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment. PLoS One. 2011; 6(5):e20267.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.